Mirabegron in medical expulsive therapy for distal ureteral stones: a prospective, randomized, controlled study

ConclusionsThe MET with Mirabegron has a significant role in improve SFR for the patients with distal ureteral stones  ≤ 5 mm and no effect in >  5 mm stones. Furthermore, Mirabegron reduces the need for antalgic in ≤ 10 mm stones with low incidence of adverse effects.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research